Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/68756
Registo completo
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Carvalho, Ricardo Emanuel Silva | por |
dc.contributor.author | Fidalgo, J. | por |
dc.contributor.author | Melo, K. R. | por |
dc.contributor.author | Queiroz, M. F. | por |
dc.contributor.author | Leal, Ana Salomé Barbosa | por |
dc.contributor.author | Rocha, H. A. | por |
dc.contributor.author | Cruz, T. | por |
dc.contributor.author | Parpot, Pier | por |
dc.contributor.author | Tomás, A. M. | por |
dc.contributor.author | Gama, F. M. | por |
dc.date.accessioned | 2020-12-29T23:07:28Z | - |
dc.date.available | 2020-12-29T23:07:28Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Silva-Carvalho, Ricardo; Fidalgo, J.; Melo, K. R.; Queiroz, M. F.; Leal, S.; Rocha, H. A.; Cruz, T.; Parpot, Pier; Tomás, A. M.; Gama, F. M., Corrigendum to Development of dextrin-amphotericin B formulations for the treatment of Leishmaniasis [Int. J. Biol. Macromol., 15 (2020) 276288]. International Journal of Biological Macromolecules, 166, 1619, 2021. | por |
dc.identifier.issn | 0141-8130 | por |
dc.identifier.uri | https://hdl.handle.net/1822/68756 | - |
dc.description.abstract | The authors regret to inform that there are some inaccuracies in the above referred article. More specifically, in the end of the Results and Discussion section 3.6. Anti-Leishmania activity against axenic promastigote and intramacrophagic L. infantum amastigotes it is described the following “Dex-AmB nanocomplexes had an activity similar to the free-drug, despite the slightly higher IC50 values - 0.017 ± 0.009 and 0.023 ± 0.006 μM for Dex-AmB FD and Dex-AmB SD, respectively - promoting a decrease in the amastigote parasite burden in the used concentration range. These results are consistent with the literature where reduced and unreduced AmB-AG conjugates were able to decrease the percentage of macrophages infected with L. infantum (ED50 of 0.035 mg/mL and 0.027 mg/mL, respectively) [75]”. In this sentence the units “mg/mL” are incorrect and the correct ones are “μg/mL”. Moreover, the reference numbered with 75 should be “J. Golenser, et al., Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives. Antimicrob Agents Chemother 43(9) (1999) 2209-14” instead of “R. Falk, et al. A novel injectable water-soluble amphotericin B-arabinogalactan conjugate. Antimicrob. Agents Chemother., 43 (8) (1999), pp. 1975-1981”. The authors would like to apologise for any inconvenience caused. | eng |
dc.description.sponsorship | (undefined) | por |
dc.language.iso | eng | por |
dc.publisher | Elsevier 1 | por |
dc.rights | openAccess | por |
dc.title | Corrigendum to “Development of dextrin-amphotericin B formulations for the treatment of Leishmaniasis” [Int. J. Biol. Macromol., 15 (2020) 276–288](S0141813019404066)(10.1016/j.ijbiomac.2020.03.019) | por |
dc.type | corrigendum | - |
dc.peerreviewed | yes | por |
dc.relation.publisherversion | http://www.elsevier.com/locate/issn/01418130 | por |
dc.comments | CEB53858 | por |
oaire.citationStartPage | 1619 | por |
oaire.citationEndPage | 1619 | por |
oaire.citationVolume | 166 | por |
dc.date.updated | 2020-12-28T00:25:07Z | - |
dc.identifier.doi | 10.1016/j.ijbiomac.2020.07.193 | por |
dc.identifier.pmid | 32797999 | por |
dc.description.publicationversion | info:eu-repo/semantics/publishedVersion | - |
dc.subject.wos | Science & Technology | por |
sdum.journal | International Journal of Biological Macromolecules | por |
Aparece nas coleções: | CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
document_53858_1.pdf | 208,6 kB | Adobe PDF | Ver/Abrir |